Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionGemmer Asset Management LLC
Latest Disclosed Ownership3,706 shares
Latest Disclosed Value $ 516,480
Gemmer Asset Management LLC reports 2.66% increase in ownership of GILD / Gilead Sciences, Inc.

On April 22, 2026 - Gemmer Asset Management LLC filed a 13F-HR form disclosing ownership of 3,706 shares of Gilead Sciences, Inc. (CH:GILD) valued at $516,480 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 3,610 shares of Gilead Sciences, Inc.. This represents a change in shares of 2.66% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F GILEAD SCIENCES COM 375558103 3,706 96 2.66 516 16.48 0.0408
2026-01-23 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,610 -18 -0.50 443 10.20 0.0341
2025-10-15 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,628 0 0.00 403 0.00 0.0325
2025-07-22 2025-06-30 13F GILEAD SCIENCES COM 375558103 3,628 1 0.03 402 -0.99 0.0357
2025-04-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 3,627 -123 -3.28 406 17.34 0.0406
2025-01-16 2024-12-31 13F GILEAD SCIENCES COM 375558103 3,750 0 0.00 346 10.19 0.0341
2024-10-24 2024-09-30 13F GILEAD SCIENCES COM 375558103 3,750 -188 -4.77 314 16.30 0.0314
2024-07-16 2024-06-30 13F GILEAD SCIENCES COM 375558103 3,938 3,938 270 0.0289
2022-07-21 2022-06-30 13F GILEAD SCIENCES COM 375558103 0 -1,027 -100.00 0 -100.00
2022-04-20 2022-03-31 13F GILEAD SCIENCES COM 375558103 1,027 -25 -2.38 61 -19.74 0.0075
2022-01-21 2021-12-31 13F GILEAD SCIENCES COM 375558103 1,052 3 0.29 76 4.11 0.0090
2021-10-19 2021-09-30 13F GILEAD SCIENCES COM 375558103 1,049 3 0.29 73 1.39 0.0101
2021-07-23 2021-06-30 13F Gilead Sciences COM 375558103 1,046 23 2.25 72 9.09 0.0099
2021-04-20 2021-03-31 13F Gilead Sciences COM 375558103 1,023 1 0.10 66 10.00 0.0103
2021-01-28 2020-12-31 13F Gilead Sciences COM 375558103 1,022 -83 -7.51 60 -14.29 0.0099
2020-10-21 2020-09-30 13F Gilead Sciences COM 375558103 1,105 1 0.09 70 -17.65 0.0130
2020-07-31 2020-06-30 13F Gilead Sciences COM 375558103 1,104 112 11.29 85 14.86 0.0179
2020-05-01 2020-03-31 13F Gilead Sciences COM 375558103 992 147 17.40 74 34.55 0.0197
2020-01-17 2019-12-31 13F Gilead Sciences COM 375558103 845 -12 -1.40 55 1.85 0.0126
2019-10-11 2019-09-30 13F Gilead Sciences COM 375558103 857 14 1.66 54 -5.26 0.0134
2019-07-18 2019-06-30 13F Gilead Sciences COM 375558103 843 1 0.12 57 3.64 0.0153
2019-04-17 2019-03-31 13F Gilead Sciences COM 375558103 842 -85 -9.17 55 -5.17 0.0150
2019-01-18 2018-12-31 13F Gilead Sciences COM 375558103 927 -9 -0.96 58 -19.44 0.0179
2018-10-12 2018-09-30 13F Gilead Sciences COM 375558103 936 -98 -9.48 72 -1.37 0.0224
2018-07-17 2018-06-30 13F Gilead Sciences COM 375558103 1,034 -6 -0.58 73 -6.41 0.0251
2018-05-11 2018-03-31 13F Gilead Sciences COM 375558103 1,040 -182 -14.89 78 -11.36 0.0268
2018-01-16 2017-12-31 13F Gilead Sciences COM 375558103 1,222 153 14.31 88 1.15 0.0304
2017-10-12 2017-09-30 13F Gilead Sciences COM 375558103 1,069 -39 -3.52 87 11.54 0.0331
2017-07-13 2017-06-30 13F Gilead Sciences COM 375558103 1,108 -17 -1.51 78 2.63 0.0326
2017-04-19 2017-03-31 13F Gilead Sciences COM 375558103 1,125 0 0.00 76 -6.17 0.0339
2017-01-13 2016-12-31 13F Gilead Sciences COM 375558103 1,125 -176 -13.53 81 -21.36 0.0408
2016-10-17 2016-09-30 13F Gilead Sciences COM 375558103 1,301 175 15.54 103 9.57 0.0524
2016-07-22 2016-06-30 13F Gilead Sciences COM 375558103 1,126 -111 -8.97 94 -16.81 0.0508
2016-04-15 2016-03-31 13F Gilead Sciences COM 375558103 1,237 -5 -0.40 113 -10.32 0.0659
2016-01-22 2015-12-31 13F Gilead Sciences COM 375558103 1,242 3 0.24 126 3.28 0.0744
2015-11-17 2015-09-30 13F/A-1 Gilead Sciences COM 375558103 1,239 -29 -2.29 122 -17.57 0.0771
2015-11-10 2015-09-30 13F Gilead Sciences COM 375558103 2,871 1,751 282 116,176.5554
2015-08-06 2015-06-30 13F Gilead Sciences COM 375558103 1,268 0 0.00 148 19.35 0.0899
2015-04-10 2015-03-31 13F Gilead Sciences COM 375558103 1,268 188 17.41 124 21.57 0.0750
2015-02-06 2014-12-31 13F Gilead Sciences COM 375558103 1,080 -40 -3.57 102 -14.29 0.0691
2014-11-03 2014-09-30 13F Gilead Sciences I COM 375558103 1,120 80 7.69 119 38.37 0.0845
2014-08-13 2014-06-30 13F Gilead Sciences COM 375558103 1,040 53 5.37 86 22.86 0.0580
2014-05-23 2014-03-31 13F Gilead Sciences COM 375558103 987 987 70 0.0500
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.